Having trouble accessing articles? Reset your cache.

U.S.-China trade deal includes patent linkage, other pharma IP protections

China has agreed to implement patent linkage and patent term extension as part of the “phase one” trade deal signed Wednesday by President Donald Trump and Chinese Vice Premier Liu He.

Read the full 310 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE